To investigate CMTM4’s function in tumor progression, CRISPR-cas9 knockout (KO) or shRNA knockdown (KD) of CMTM4 in different tumor cell lines was performed (Appendix Fig. S4A,B). This evidence concerns the gene CMTM4 and neoplasm.